SCHEMBL20705654

SCHEMBL20705654

CNCC1CC1C(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 2/20 0.41
SLC6A4 P31645 2/20 0.35
HTR2A P28223 1/20 0.33
HTR2B P41595 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19414030 0.73 HTR2C (0.32) HTR2C
SCHEMBL10831129 0.72
SCHEMBL22292261 0.69
SCHEMBL25641649 0.69
SCHEMBL25641637 0.69
SCHEMBL18509201 0.69 HTR2C (0.32) HTR2C
SCHEMBL19715628 0.67
SCHEMBL2212908 0.67
SCHEMBL19407196 0.67
SCHEMBL2022302 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2607334-B1 SINTERED ZIRCONIA, AND SINTERING COMPOSITION AND CALCINED OBJECT THEREFOR NORITAKE CO LTD (JP) 2021-05-26 EP disclosed
US-10195286-B2 Compounds and methods for trans-membrane delivery of molecules APOSENSE LTD. (IL) 2019-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10195286-B2 Compounds and methods for trans-membrane delivery of molecules SLCO2B1, SLCO1B1, ABCB4 HTR2C 4707/4885SLC6A4 279/4885HTR2A 3516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.